In short, the two peptides may both touch angiogenesis, but they start from different molecular machinery, and neither pathway has been shown to produce a human tissue-repair outcome
A drug that is right for one person could be harmful to another due to differences in health conditions, other medications, or dosing needs
Eliminating them may create a more favourable environment for stem/progenitor cells, enhance wound healing, cartilage repair, organ repair
A single COA reused across multiple batches means they are not testing each production run independently
Research in rat models of ileoileal anastomosis healing, for instance, shows that BPC-157: BPC-157 reduced adhesion formation and necrosis, while accelerating the resolution of edema and inflammatory infiltrates in treated animals compared to controls